antithrombotic diflunisal esters (Thrombostat)

N/A

Report date: 2025/03/14 20:00:48

NME

Base Information

Drug Nameantithrombotic diflunisal esters (Thrombostat)

Drug Alias Nameantithromboxane A2 (Thrombostat)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionCoagulation factor inhibitorsThromboxane A2 synthase inhibitors

TargetsThromboxane A2 synthaseCoagulation factor

Therapy Area/IndicationsCardiovascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesThrombostat Pty Ltd

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsCardiovascular Diseases

ATC CodeN/A